DEVELOPMENT AND VALIDATION OF A BIOANALYTICAL RP-HPLC METHOD FOR AZILSARTAN MEDOXOMIL WITH LIQUID-LIQUID EXTRACTION

  • Snehal Karpe MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik, Maharashtra, India
  • Sandeep Sonawane MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik, Maharashtra, India
  • Priya Rahade MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik, Maharashtra, India
  • Sanjay Kshirsagar MET’s Institute of Pharmacy, MET League of Colleges, Bhujbal Knowledge City, Adgaon, Nashik, Maharashtra, India

Abstract

Objective: There are many analytical methods available for estimation of Azilsartan medoxomil in biological samples and for pharmaceutical preparations. However, no specific RP-HPLC method with UV detection based on liquid-liquid extraction technique is available for estimation of Azilsartan medoxomil in human plasma.

Methods: A simple, rapid and accurate RP-HPLC with UV detection method was developed and validated as per US-FDA guidelines for the estimation of Azilsartan medoxomil in spiked human plasma using liquid-liquid extraction technique.

Results: Azilsartan medoxomil was well resolved from human plasma interference and internal standard (Aceclofenac) using C 18 (250 × 4.6 mm, 5 μ) column with methanol: 20 mm phosphate buffer (pH 3.0), (70: 30 %, v/v) as mobile phase, at a flow rate of 1 ml/min. The detection was performed at 249 nm. The calibration curve was found linear in the range of 500-16000 ng/ml. During calibration experiments, the heteroscedasticity was minimized by using weighted least square regression model with weighing factor 1/x². In accuracy and precision studies, intra-day and inter-day, % relative error was found between±15 and % RSD was less than 15 %. Stability experiments indicated that the drug remained stable after three freeze-thaw cycles.

Conclusion: A simple, rapid and accurate RP-HPLC method with UV detection was developed and validated for estimation of Azilsartan medoxomil based on liquid-liquid extraction technique. The developed method meets the requirements of US-FDA guidelines. Also the developed method does not require expensive chemicals and solvents and does not involve complex instrumentation, hence it is economic.

 

Keywords: Azilsartan medoxomil, Bioanalytical, Heteroscedasticity, Liquid-liquid extraction, RP-HPLC, Weighted regression

Downloads

Download data is not yet available.

References

1. National Center for Biotechnology Information. PubChem Compound Database; CID=11238823. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/11238823. [Last accessed on 10 Oct 2015].
2. Ojima M, Igata H, Tanaka M, Sakamoto H, Kuroita T, Kohara Y, et al. In antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan in receptor binding and functional studies. J Pharmacol Exp Ther 2011;336:801-8.
3. Vekariya PP, Joshi HS. Development and validation of RP-HPLC method for azilsartan medoxomil potassium quantitation in human plasma by solid phase extraction procedure. ISRN Spectroscopy; 2013. doi: 10.1155/2013/572170. [Article in Press]
4. Cheng G, Junfeng W, Yinghua S, Dawei D, Zhong L, Meng Z, et al. UPLC-MS/MS for the determination of Azilsartan in beagle dog plasma and its application in a pharmacokinetics study. Asian J Pharm Sci 2014;10:247-53.
5. Gandhi SV, Mittal PS, Pahade AR, Rege SW. Development and validation of stability indicating HPTLC method for estimation of Azilsartan medoxomil. Int J Pharm Sci 2014;6,224-32.
6. Mantena BPV, Sumathi VR, Appa Rao KMCh, Ramakrishna K, Reddy RS. Method development and validation for the determination of potential impurities present in azilsartan medoxomil tablets by reverse phase-ultra performance liquid chromatography. Anal Chem Lett 2014;4:287-301.
7. Raja G, Nagaraju CH, Sreenivasulu B, Sreenivas N, Korupolu RB. New simple UV spectrophotometric method for determination of azilsartan medoxomil in bulk and pharmaceutical dosage forms. Int J Res Pharm Biomed Sci 2013;4:1133-7.
8. Rachumallu R, Puttrevua SK, Bhateriaa M, Balab V, Sharmab VL, Bhattaa RS. Simultaneous determination of Azilsartan and Chlorthalidone in rat and human plasma by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 2015;990:185-97.
9. Naazneen S, Sridevi A. Stability indicating RP-HPLC method for the simultaneous estimation of azilsartan medoxomil and chlorthalidone in solid dosage forms. Int J Pharm Pharm Sci 2014;6:236-43.
10. Walid ME, Elkady FB, El-Zaher A, El-Bagary RI, Patonay G. Spectrophotometric and spectrofluorometric studies on azilsartan medoxomil and chlorthalidone to be utilized in their determination in pharmaceuticals. Anal Chem Insights 2014;9:33–40.
11. Nagaraja NV, Paliwal JK, Gupta RC. Choosing the calibration model in assay validation. J Pharm Biomed Anal 2012;20:433-8.
12. Bolton S, Bon C. Linear regression and correlation In: Pharmaceutical Statistics Practical and Clinical Applications. Vol. 203. Informa Healthcare USA, Inc; 2010. p. 147-81.
13. US Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, Guidance for industry-Bioanalytical method validation; 2013. Available from: http://www.fda.gov/downloads/drugs/ guidance-compliance regulatory information/guidances/ucm368107.
Statistics
325 Views | 956 Downloads
How to Cite
Karpe, S., S. Sonawane, P. Rahade, and S. Kshirsagar. “DEVELOPMENT AND VALIDATION OF A BIOANALYTICAL RP-HPLC METHOD FOR AZILSARTAN MEDOXOMIL WITH LIQUID-LIQUID EXTRACTION”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 2, Feb. 2016, pp. 164-8, https://innovareacademics.in/journals/index.php/ijpps/article/view/9887.
Section
Original Article(s)